News Medical

COVID-19 does not increase the risk of Streptococcus pneumoniae infection

In a recent study posted to the medRxiv* preprint server, researchers investigate the effect of colonization of the upper respiratory tract (URT) by Streptococcus pneumoniae on severe acute ...
Kaleido Scope

An atlas of S. pneumoniae and host gene expression during colonization and disease

To understand how this pathogen adapts to different locations in the body, and also how the host responds to the invading microbe, researchers at the University of Alabama at Birmingham, the ...
News Medical

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Bacterial colonization in the upper respiratory tract is considered to be one of the major risk factors of COVID-19. In this context, studies have shown that the co-occurrence of invasive pneumococcal ...
Medical Xpress

S. pneumoniae sticks to dying lung cells, worsening secondary infection following flu

A bout with flu virus can be hard, but when Streptococcus pneumonia enters the mix, it can turn deadly. Now researchers have found a further reason for the severity of this dual infection by ...
startupticker.ch

Zurich-based biotechs make headway

Virometix has revealed encouraging Phase 1 data for their lead vaccine asset, V-212, a synthetic vaccine designed to prevent pneumococcal disease caused by Streptococcus pneumoniae. In parallel, ...
Medscape

Macrolide-Resistant Streptococcus pneumoniae: Clinical Implications for the Empiric Treatment of Community-Acquired Respiratory Tract Infections

Readers are encouraged to respond to George Lundberg, MD, Editor of MedGenMed, for the editor's eye only or for possible publication via email: [email protected] Disclosure: Stephen Brunton, MD, ...
Business Wire

Affinivax and Astellas Present Safety and Immunogenicity Data from Phase 2 Study of ASP3772, a Novel 24 valent MAPS™ Vaccine for Streptococcus pneumoniae

CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Affinivax, Inc. ("Affinivax") and Astellas Pharma Inc. (“Astellas”) announced results from the Phase 2 clinical trial of ASP3772, a novel vaccine candidate ...
JSTOR Daily

Emergence of Antibody to Capsular Polysaccharides of Streptococcus pneumoniae during Outbreaks of Pneumonia: Association with Nasopharyngeal Colonization

Antibody to pneumococcal capsular polysaccharides (PPS) of Streptococcus pneumoniae plays a major role in protecting the host against pneumococcal infection. A variable proportion of healthy adults ...
Medscape

Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae

Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...
Science Daily

An atlas of S. pneumoniae and host gene expression during colonization and disease

The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread to the bloodstream and cause organ damage. To understand how this pathogen adapts to ...
Science Daily

Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu

Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria ...